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Background: Abroma augusta L. (Malvaceae) leaf is traditionally used to treat diabetes in India and Southern Asia.
Therefore, current study was performed to evaluate the protective effect of defatted methanol extract of A. augusta
leaves (AA) against type 2 diabetes mellitus (T2DM) and its associated nephropathy and cardiomyopathy in
experimental rats.
Methods: Antidiabetic activity of AA extracts (100 and 200 mg/kg, p.o.) was measured in streptozotocin-nicotinamide
induced type 2 diabetic (T2D) rat. Fasting blood glucose level (at specific interval) and serum biochemical markers
(after sacrifice) were measured. Redox status, transcription levels of signal proteins (NF-κB and PKCs), mitochondria
dependent apoptotic pathway (Bad, Bcl-2, caspase cascade) and histological studies were performed in kidneys and
hearts of controls and AA treated diabetic rats.
Results: Phytochemical screening of extracts revealed the presence of taraxerol, flavonoids and phenolic compounds
in the AA. T2D rats showed significantly (p < 0.01) elevated fasting blood glucose level. Alteration in serum lipid profile
and release of membrane bound enzymes like lactate dehydrogenase and creatine kinase, which ensured the
participation of hyperlipidemia and cell membrane disintegration in diabetic pathophysiology. T2DM caused alteration
in the serum biochemical markers related to diabetic complications. T2DM altered the redox status, decreased the
intracellular NAD and ATP concentrations in renal and myocardial tissues of experimental rats. Investigating the
molecular mechanism, activation PKC isoforms was observed in the selected tissues. T2D rats also exhibited an
up-regulation of NF-κB and increase in the concentrations of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) in the
renal and cardiac tissues. The activation of mitochondria dependent apoptotic pathway was observed in renal and
myocardial tissues of the T2D rats. However, Oral administration of AA at the doses of 100 and 200 mg/kg body weight
per day could reduce hyperglycemia, hyperlipidemia, membrane disintegration, oxidative stress, vascular inflammation
and prevented the activation of oxidative stress induced signaling cascades leading to cell death. Histological studies
also supported the protective characteristics of AA.
Conclusions: Results suggest that AA could offer prophylactic role against T2DM and its associated reno- and
cardio- toxicity.
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Diabetes mellitus (DM) is a chronic metabolic disorder
characterized by hyperglycemia which may be due to
unusual discharge of insulin and/or resistance to insu-
lin. The disease has a significant effect on social, psycho-
logical as well as physical quality of life [1]. Approximately
366 million people are suffering from DM around the
world and the incidence of this disease is predicted to be
more than double by the year of 2030 [2]. Non-insulin
dependent or Type 2 DM (T2DM) is most prevalent
among various types of DM, which comprises ~ 90–95%
of all diagnosed cases of DM [3]. The persistent hypergly-
cemia is accountable for the damages of various organs
and tissues in diabetic patients. However, diabetic compli-
cations are not merely due to hyperglycemia. Previous in-
vestigations have indicated that oxidative stress is a key
factor in etiology of diabetic complications like cardiomy-
opathy and nephropathy [4,5]. However, the exact source
of oxidative free radicals is yet to be recognized. Mito-
chondrial dysfunction, advanced glycation end processes
and others are believed to be the probable sources [6].
Generation of oxidative free radicals results in oxidative
disruption of structural proteins and degradation of
membrane-bound-phospholipids. Moreover, reactive free
radicals cause fragmentation of DNA, which results apop-
totic cell death [7]. Oxidative stress also leads to impair-
ment of endogenous antioxidant enzymes due to their
non-enzymatic glycosylation and auto-oxidation [8].
These super-active radicals may also disturb the expres-
sions of several transcription proteins like NF-κB,
PKCs, caspases etc. [4]. It is well-known that inflamma-
tory cytokines viz. TNF-α, IL-6 and IL-1β play key roles
in the cascade of inflammation and systemic insulin resist-
ance and thereby participate directly in diabetic nephropa-
thy and cadiomyopathy [4]. Therefore, it is important to
counteract diabetic pathophysiology through multi-target
therapeutic agent. Multi-component plant extract (chem-
ically standardized) could offer this multimodal thera-
peutic value.
Abroma augusta L. (Malvaceae), an evergreen shrub, is
found throughout the hot and humid parts of India.
Leaves and seeds of A. augusta are considered to be ed-
ible in India and New Guinea. A. augusta has an all-
embracing history in Ayurvedic system. Leaves are used
as a remedy for diabetes, inflammation, rheumatic pain
of joints, uterine disorders, and headache [9-11]. The
whole plant contains alkaloids, steroids, triterpenes, fla-
vonoids, megastigmanes, and phenylethanoid glycosides
[12]. Since the selected plant species was claimed to pos-
sess both anti-diabetic and anti-inflammatory activities,
the present investigation was performed to evaluate the
protective effect of A. augusta leaves on T2DM and its
associated pathogenesis in renal and cardiac tissues.
Streptozotocin-nicotinamide induced T2DM model onexperimental rats was chosen for this study. The effect
of test drug on fasting blood glucose level, serum lipid
profile and other biochemical markers associated with
diabetic pathogenesis was investigated. The protective
effect of A. augusta leaves on oxidative stress and in-
flammation mediated pathogenesis was investigated and
mechanism by which AA exerts its protective effect was
evaluated by estimating the transcription levels of signal
proteins. Finally, histopathological studies of kidney and




Mature leaves of A. augusta were collected from Howrah
district, West Bengal, India in May, 2013. The plant ma-
terial was authenticated (Ref no. CNH/45/2013/Tech.II/
1070) by Dr. V. P. Parsad, Taxonomist, Central National
Herbarium, Botanical Survey of India, Shibpur, India. A
voucher specimen JU/PT/PC/04/2013 was submitted at
Advanced Pharmacognosy Research Laboratory, Depart-
ment of Pharmaceutical Technology, Jadavpur University,
India. The dried powdered leaves (2.5 kg) were macerated
with MeOH (4 × 10 l) with continuous agitation. The
MeOH extract (312 g, yield ≈ 12.5% w/w) was dissolved in
Et2O (30°C) for removal of fat and waxes. The residue
(AA, 210 g) was subjected in this study.
Phytochemical analysis
Preliminary phytochemical analysis (TLC studies followed
by spraying the chromatogram with specific reagents) re-
vealed presence of triterpenoids, steroids, flavonoids and
phenolic compounds in AA. Based on the preliminary
phytochemical studies, AA was subjected further for
detailed phytochemical profiling. AA (100 g) was ex-
tracted with CH2Cl2 (5 × 3 l) to yielding 26 g of CH2Cl2
soluble fractions which was enriched with steroids and
triterpenoids. CH2Cl2 fractions were subjected to silica
gel-column chromatography using mixtures of n-hexane-
EtOAc and EtOAc-MeOH of increasing polarity to yield
fractions (A-F). Fraction A (0.38 g) was chromatographed
with n-hexane-CH2Cl2 and CH2Cl2-MeOH, to yield com-
pound 1 (12 mg). Fraction B (2.5 g) was chromatographed
with n-hexane-CH2Cl2 and CH2Cl2-MeOH to yield com-
pound 2 (72 mg). Fraction C (0.65 g) and fraction D
(0.32 g) also yielded compound 2 of 25 and 11 mg, re-
spectively. Fraction E (10.5) was chromatographed with n-
hexane-CH2Cl2 and CH2Cl2-MeOH to yield compound 3
(24 mg). RP-HPLC analysis of AA was performed to de-
tect presence of phenolics and flavonoids by comparing
with reference phytochemical markers. Chromatographic
studies were performed by HPLC (Dionex Ultimate 3000,
Germany), having a UV detector and a C-18 RP column
(250 × 4.6 mm, particle size 51). The samples were
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0.45 μm nylon membrane filter (Pall Life Science, USA).
The aliquots of the filtrate were eluted with isocratic solv-
ent mixture comprising methanol:acetonitrile:acetic acid:
o-phosphoric acid: water (20:10:1:1:20) for flavonoids and
methanol:water:acetic acid (25:74:1) for phenolic com-
pounds with flow rate of 1 ml min−1 and detected at 340
and 254 nm respectively.Animals
Animal models comprised of male Wistar rats (weight
180 ± 20 g; age 2–3 months). The rats were housed in
standard polyprophylene cages under standard lab con-
ditions of 12 h light–dark cycle, temperature (20 ± 2°C),
relative humidity (50 ± 15%), standard diet and water ad
libitum. The animal experiments were pursued at the De-
partment of Pharmaceutical Technology, Jadavpur Univer-
sity, India (CPCSEA Reg. No. 0367/01/C/CPCSEA). The
institutional animal ethical committee instructions as well
as principles of laboratory animals care [13] were followed
throughout experiment.Oral Glucose Tolerance Test (OGTT)
Overnight fasted male Wistar rats were divided into 3
groups of 6 rats each. OGTT was performed by treating
the animals with glucose (1.5 g/kg, p.o.) [14]. Just after
glucose feeding, two groups of rats were fed with AA
(100, 200 mg/kg, p.o., respectively). A group of animals
were treated with double distilled water (2 ml/kg, p.o.)
and kept as control. Blood glucose levels were measured
at 0, 30, 60, and 120 min after glucose treatment with the
help of single touch glucometer (Ascensia Entrust, Bayer
Health Care, USA). Total glycaemic responses were calcu-
lated from respective areas under the curve (AUC) during
the 120 min of observation period.Comparison between streptozotocin and streptozotocin-
nicotinamide model
Overnight fasted male Wistar rats were divided into 3
groups of 6 rats each. One group of animals received
single intraperitonial injection (i.p.) of streptozotocin
(65 mg/kg) in citrate buffer (pH 4.5). The other group of
rats were treated with nicotinamide (110 mg/kg, i.p.)
followed by (after 15 min) streptozotocin (65 mg/kg, i.p.)
in citrate buffer (pH 4.5) [15]. One group of rats without
treatment served as control. After 1 week, animals were
subjected to fasting blood glucose level and insulin level
measurements. Fasting blood serum glucose level was
measured by single touch glucometer (Ascensia Entrust,
Bayer Health Care, USA). Serum insulin was also mea-
sured by kits (Span Diagnostics Ltd., Surat, India) fol-
lowing manufacturer protocol.Induction of T2DM and experimental design
T2DM was induced in overnight fasted rats by a single in-
traperitoneal injection (i. p.) of streptozotocin (65 mg/kg)
in citrate buffer (pH 4.5), 15 min later the administration
of nicotinamide (110 mg/kg, i. p.) [15]. After 1 week,
animals exhibiting fasting glucose levels between 140–
200 mg/dl were screened as type 2 diabetic (T2D) rats
and were used for the antidiabetic assay. Animals were
divided into 5 groups of 6 rats each as follows:
Gr I: Normal rats were given double distilled water
(2 ml/kg, p.o.) daily for 4 weeks;
Gr II: T2D control rats were given distilled water
(2 ml/kg, p.o.) daily for 4 weeks;
Gr III: T2D rats were given AA (100 mg/kg, p.o.) daily
for 4 weeks;
Gr IV: T2D diabetic rats were given AA (200 mg/kg,
p.o.) daily for 4 weeks;
Gr V: T2D rats were given standard drug glibenclamide
(1 mg/kg, p.o.) [5] daily for 4 weeks.
Serum biochemical analysis
Single touch glucometer (Ascensia Entrust, Bayer Health
Care, USA) was utilized to estimate fasting blood glu-
cose level on day 0, 1, 3, 7, 14, 21 and 28. For estimation
of serum biochemical parameters, eppendroff tubes
rinsed with anticoagulants were used for collection of
blood samples after 28 days. From this blood, serum was
separated by centrifugation at 3000 g for 10 min [5]. En-
zymatic colorimetric kits (Span Diagnostics Ltd., Surat,
India) were used for determination of serum triglyceride
and cholesterol profiles while serum insulin was measured
by kits (Span Diagnostics Ltd., Surat, India) following
manufacturers protocols. Glycosylated hemoglobin was es-
timated according to method of Nayak and Pattabiraman
[16]. Lipid profile (total cholesterol, HDL cholesterol, and
triglyceride), alanine aminotransferase (ALT) and aspartate
aminotransferase (AST), urea and the membrane leakage
enzymes (creatine kinase and lactate dehydrogenase) were
assessed by standard kits (Span Diagnostic Limited, India)
following manufacturer protocol.
Organs’ biochemical analysis
The rats were anesthetized and sacrificed by cervical dis-
location after 28 days. The organs (heart and kidney) were
excised, cleaned and washed with ice-cold saline (pH 7.4).
The organs were homogenized in Tris–HCl (0.1 M)-
EDTA buffer (pH 7.4, 0.001 M) and centrifuged at
12,000 g for 30 min at 4°C. Biochemical parameters were
assessed from collected supernatant. The intracellular re-
active oxygen species (ROS) production was measured by
the method of LeBel and Bondy [17] with a minor modifi-
cation introduced by Kim et al. [18]. Fluorescence spec-
trometer (Hitachi, F4500) set at excitation wavelength of
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measurement of 2', 7'dichloro-fluorescein (DCF) forma-
tion. The extent of lipid peroxidation was measured by
evaluating thiobarbituric cid reactive substances (TBARS)
following the protocol of Ohkawa et al. [19]. Protein car-
bonylation was estimated by method of Uchida and Stadt-
man [20]. Co-enzymes Q (Q9 and Q10) were isolated and
estimated according to the method of Zhang et al. [21].
Reduced glutathione (GSH) level was measured by Hissin
and Hilf ’s method [22]. Activity of antioxidant enzymes
like catalase (CAT), superoxide dismutase (SOD), glutathi-
one peroxidase (GPx), glutathione-6-phosphate dehydro-
genase (G6PD) and glutathione reductase (GR) was
estimated by the methods reported by Ghosh et al. [23].
Homogenates were screened for NAD by colometric
method [24] while intracellular ATP concentrations were
assessed by commercial kits (Abcam, Cambridge, USA)
following manufacturer protocol.
Immunoblotting
SDS-PAGE (10%) was used for separation of proteins from
20 μg protein sample and transferred into nitrocellulose
membrane. These membranes were blocked (blocking
buffer containing 5% non-fat dry milk) for 1 h at room
temperature and later incubated with primary antibodies
(anti-rat antibodies produced in rabbit) viz. anti-Bcl-2
(1:500), anti-Bax (1:500), anti-caspase 3 (1:1000), anti-
PKC-α (1:500), anti-PKC-β (1:500), anti-PKC-δ (1:500),
anti-PKC-ε (1:500), anti-NF-κB (1:1000), and anti-β-actin
(1:1000) antibodies at 4°C overnight. Tris-Buffered Saline
with 0.1% Tween 20 (pH 7.6) was used for washing of
membranes for 15 min, incubated with appropriate HRP
conjugated secondary antibody (anti-rabbit antibodies
produced in goat) at 1:2000 dilutions at room temperature
for 2 h and developed by HRP substrate 3, 3'- diaminoben-
zidine tetrahydrochloride system (Banglore genei, India).
Assay of inflammatory cytokines
Concentrations of inflammatory cytokines (IL-1β, IL-6,
TNF-α) in cardiac and renal tissue samples were ana-
lyzed by ELISA. A labsystem integrated EIA Manage-
ment System iEMS and Delta Soft 32.22 EMS software
was used for measurement of optical density.
Histological studies
Isolated organs from normal and experimental rats were
fixed in buffered formalin (10%) and processed for paraf-
fin sectioning. Sections obtained (approx. 5 μm) were
stained by hematoxylin and eosin to study the histology
of isolated organs [25].
Statistical analysis
One-way ANOVA was utilized for statistical analysis of
data and expressed as mean ± SE followed by Dunnett’st-test using computerized GraphPad InStat (version
3.05), GraphPad software, USA. The values were consid-
ered significant when p < 0.05.
Results and discussion
Phytochemical analysis
The structures of isolated compounds were characterized
by analyzing NMR and mass spectrometric data. Com-
pound 1, 2 and 3 were identified as taraxerone, taraxerol
and stigmasterol (Additional file 1: Figure S1). The phen-
olic and flavonoid compound were identified by RP-HPLC
and comparing retention time (Rt) and UV spectra with
standard marker compounds. HPLC analysis revealed
presence of flavonoids viz. rutin (22.4 mg g-1DW, Rt: 3.0),
myricetin (14.1 mg g-1DW, Rt: 3.9), quercetin (19.8 mg
g-1DW, Rt: 5.6) and apigenin (19.2 mg g
-1DW, Rt: 8.1)
(Additional file 1: Figure S2), the phenolic compounds
viz. gallic acid (17.2 mg g-1DW, Rt: 4.03) and chlorogenic
acid (19.1 mg g-1DW, Rt: 7.24) in AA (Additional file 1:
Figure S3).
Effect on OGTT
With the intent to assess the effect of AA on systemic
glucose homeostasis, OGTT was performed (Figure 1A).
The OGTT study revealed that, oral administration of
AA (100, 200 mg/kg) significantly (p < 0.05-0.01) re-
duced blood glucose concentrations between 30–60 min
after glucose (1.5 mg/kg) load. The AA also exerted a
significant influence on total glycaemic response evi-
denced by the significant reduction of AUC as compared
with control group during an OGTT (Figure 1B).
Effect of streptozotocin (singly) and streptozotocin in
combination with nicotinamide
In this study, the effect of streptozotocin (singly) and
streptozotocin in combination with nicotinamide was
compared (Figure 1C). Both treatments offered a signifi-
cant elevation of fasting blood glucose level (p < 0.01)
with concomitant depletion (p < 0.01) of serum insulin
level, when compared with normal rats. However, a single
intraperitoneal injection (i.p.) of streptozotocin (65 mg/
kg) caused nearly complete destruction of β-cells of pan-
creas resulting an elevated fasting blood glucose level
(~270-360 mg dl−1) with a sharp depletion of insulin level
(~0.6 μg dl−1). On other hand, the rats exposed to nico-
tinamide prior to streptozotocin exhibited a blood glucose
level ranging between ~160-200 mg dl−1 and insulin level
of ~ 1.8 μg dl−1 after day 7. The statistical comparison be-
tween streptozotocin and streptozotocin-nicotinamide
treated group revealed a significant difference between
fasting blood glucose (p < 0.05) and serum insulin (p < 0.01)
levels. The experimental outcome would refer that nico-
tinamide offers a partial protection against β-cytoxic effect
of streptozotocin [15]. Masiello et al. [15] claimed that
Figure 1 Effect of AA on oral glucose tolerance test (A); the areas under the curve (AUC) were calculated using the trapezoid method (B);
comparison between the effects of streptozotocin (singly) and streptozotocin-nicotinamide (in combination) on adult rats (C). Data were
expressed as mean ± SE (n = 6). *p < 0.05 compared with control group. **p < 0.01 compared with control group. #p < 0.05 compared with
streptozotocin-nicotinamide treated rats. $p < 0.01 compared with streptozotocin-nicotinamide treated.
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tion of pancreatic insulin stores and developed T2DM
in adult rats. Therefore, streptozotocin-nicotinamide
model has been chosen for this study to evaluate oral
hypoglycemic effect of AA.
Effect on fasting blood glucose level and serum
biochemical parameters
A significantly (p < 0.01) high fasting blood glucose level
(170–190 mg/dl) was observed in T2DM rats. Mainten-
ance of blood glucose level within normal range is a pri-
mary approach during T2DM treatment. AA (100 and
200 mg/kg) treatment could significantly reduce fasting
blood glucose level in T2D rat with maximum reductionTable 1 Effect of AA on fasting blood glucose level of T2D rat
Groups Fasting blood glucose level (mg dl−1) in days
0 1 3 7
Gr I 76.48 ± 3.74 76.04 ± 4.08 76.21 ± 3.99 75.8
Gr II 171.90 ± 6.99# 172.28 ± 6.91# 177.44 ± 7.45 180
Gr III 170.63 ± 9.02# 168.08 ± 8.76# 146.33 ± 9.77* 142
Gr IV 173.22 ± 5.46# 165.67 ± 7.39# 142.40 ± 5.64** 136
Gr V 175.32 ± 7.94# 168.88 ± 8.85# 138.84 ± 5.59** 125
Data were expressed as mean ± SE (n = 6). #p < 0.01 compared with normal control
**p < 0.01 compared with diabetic control group. Gr I: Normal; Gr I: Normal; Gr II: T2
Gr V: T2D + glibenclamide (1 mg/kg, p.o.).of ~ 32.2% (p < 0.01) and ~ 40.5% (p < 0.01) on day 28, re-
spectively. The standard drug glibenclamide (1 mg/kg)
exhibited maximum reduction of ~ 48.3% (p < 0.01) on
day 28 (Table 1). Biological effects of AA on serum bio-
chemical parameter were shown in Table 2. T2DM is as-
sociated with hyperlipidemia [26]. Investing the lipid
profile, significantly (p < 0.01) high levels of total choles-
terol, triglycerides with concomitant low HDL choles-
terol (p < 0.01) level were observed in the T2D rats,
which could suggest the association between hypergly-
cemia and hyperlipidemia. A significant (p < 0.01) reduc-
tion of serum insulin content was observed in T2D rats.
It is well-recognized that lipo-protein lipase is activated
by insulin which hydrolyzes triglycerides under normals
14 21 28
4 ± 3.62 75.63 ± 2.63 77.22 ± 2.87 76.43 ± 3.12
.77 ± 6.82# 184.13 ± 7.26# 187.15 ± 6.15# 190.47 ± 6.03#
.64 ± 9.38** 138.88 ± 4.08** 133.27 ± 3.04** 129.10 ± 3.39**
.08 ± 6.56** 126.64 ± 4.82** 121.47 ± 5.27** 113.39 ± 4.70**
.71 ± 5.75** 113.16 ± 4.49** 108.45 ± 3.73** 98.40 ± 2.83**
group. *p < 0.05 compared with diabetic control group.
D control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg, p.o.);
Table 2 Effect of AA on serum biochemical parameters of T2D rats
Parameters Gr I Gr II Gr III Gr IV Gr V
Total cholesterol (mg dl−1) 87.12 ± 3.60 131.32 ± 3.73# 104.22 ± 5.02* 97.53 ± 3.70** 94.43 ± 3.67**
HDL-cholesterol (mg dl−1) 33.10 ± 2.94 18.14 ± 1.13# 24.61 ± 2.41 28.98 ± 3.60* 31.38 ± 3.17**
Triglycerides (mg dl−1) 76.27 ± 3.78 123.08 ± 6.13# 104.22 ± 5.67 96.40 ± 7.10* 82.62 ± 5.60**
Insulin (μg dl−1) 2.68 ± 0.18 1.64 ± 0.14# 2.02 ± 0.11 2.17 ± 0.10* 2.23 ± 0.14*
Glycosylated haemoglobin (mg g−1 haemoglobin) 0.27 ± 0.45 0.67 ± 0.62# 0.49 ± 0.73 0.42 ± 0.65* 0.39 ± 0.33**
ALT (IU l−1) 69.83 ± 4.16 101.43 ± 7.49# 84.55 ± 6.35 79.33 ± 5.13* 73.98 ± 6.13*
AST (IU l−1) 45.32 ± 4.09 71.69 ± 4.47# 58.91 ± 5.38 54.69 ± 6.81 51.20 ± 6.34*
Urea (mg dl−1) 30.63 ± 2.41 65.04 ± 4.99# 46.56 ± 3.88** 44.76 ± 3.07** 41.86 ± 3.52**
Lactate dehydrogenase (U l−1) 207.52 ± 9.36 294.04 ± 15.24# 253.75 ± 15.68 242.82 ± 13.10* 238.33 ± 9.98*
Creatinine kinase (IU mg−1 protein) 4.73 ± 0.38 8.21 ± 0.50# 6.54 ± 0.57 6.12 ± 0.39* 5.76 ± 0.45**
C-reactive protein (mg dl−1) 1.02 ± 0.10 3.24 ± 0.24# 2.18 ± 0.24* 2.09 ± 0.32** 1.61 ± 0.19**
Data were expressed as mean ± SE (n = 6). #p < 0.01 compared with normal control group. *p < 0.05 compared with diabetic control group.
**p < 0.01 compared with diabetic control group. Gr I: Normal; Gr I: Normal; Gr II: T2D control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg, p.o.);
Gr V: T2D + glibenclamide (1 mg/kg, p.o.).
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sulin secretion and/or responsiveness could be the cause
of hyperlipidemia in T2DM. However, AA could signifi-
cantly reinstate the serum lipids (p < 0.05-0.01) and
insulin (p < 0.05) levels near to the normalcy. The experi-
mental observation could suggest that AA exerts anti-
hyperglycemic and anti-hyperlipidemic effects through
promoting insulin secretion. The increase in blood glucose
level is responsible for the increased glycosylation of a
number of proteins including haemoglobin [4,27]. In this
study, T2DM rats exhibited a significantly (p < 0.01) ele-
vated glycosylated-haemoglobin level. AA (200 mg/kg)
treatment could significantly (p < 0.05) reverted the
glycosylated-haemoglobin level near to the normal status.
A reduction of glycosylation of haemoglobin is account-
able to the anti-hyperglycemic effect of AA. Type 2 dia-
betic rats exhibited significantly (p < 0.01) increased levels
of serum AST, ALT and urea as compared with normal
control group. An increase in ALT and AST levels in
blood may indicate degenerative and necrotic changes in
livers (not included in this manuscript), kidneys and heart
[7,28,29]. An increased serum level of urea may be associ-
ated with protein catabolism and kidney dysfunction [30].
Treatment with AA could significantly lower the levels of
serum ALT and urea as compared with diabetic controlTable 3 Effect of AA on body weight and organ weight of T2D
Groups Total body weight (g)
Gr I 216.67 ± 7.15
Gr II 171.67 ± 5.58#
Gr III 188.33 ± 6.91
Gr IV 192.50 ± 5.44
Gr V 200.83 ± 8.60*
Data were expressed as mean ± SE (n = 6). #p < 0.01 compared with normal control
with diabetic control group. Gr I: Normal; Gr I: Normal; Gr II: T2D control, Gr III: T2D + A
(1 mg/kg, p.o.).rats, while, no significant effect was observed in AST level.
Increased creatinine kinase and lactate dehydrogenase
content are the major indicators of cellular damage [31].
Usually, these membranes bound enzymes leak out into
the plasma during cellular injury due to disintegration of
contractile elements and sarcoplasmic reticulum [31]. In
present investigation, both lactate dehydrogenase and
creatinine kinase levels in the sera were significantly
(p < 0.01) elevated in T2D animals (Table 2). However,
treatment with AA (200 mg/kg) could significantly (p <
0.05) revert the levels of lactate dehydrogenase and cre-
atinine kinase as compared with T2D control rats. In
this experiment, C-reactive protein activities were sig-
nificantly up-regulated in diabetic animals. It is re-
ported that the incidence of diabetes is linked with
higher levels of various inflammatory parameters like
C-reactive proteins [4]. An elevated level of serum C-
reactive proteins vindicated the inflammation mediated
damage of critical tissues. Treatment with AA could
significantly (p < 0.05-0.01) reduce the C-reactive pro-
tein levels in a dose-dependent manner.
Effect on body and organs’ weight
In the present study, total body weight and the
weights of kidney and heart was measured (Table 3). Arats
Kidney weight (g) Heart weight (g)
0.95 ± 0.05 0.47 ± 0.03
1.41 ± 0.08# 0.52 ± 0.03
1.17 ± 0.06 0.53 ± 0.04
1.12 ± 0.09* 0.52 ± 0.04
1.02 ± 0.06** 0.51 ± 0.02
group. *p < 0.05 compared with diabetic control group. **p < 0.01 compared
A (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg, p.o.); Gr V: T2D + glibenclamide
Table 4 Effect of AA on ROS production, lipid peroxidation (TBARS), protein carbonyation, ubiquinones
(coenzyme Q9 and Q10) and GSH level of T2D rats
Parameters Gr I Gr II Gr III Gr IV Gr V
Kidney
ROS production (nmol DCF min−1 mg−1 of protein) 36.84 ± 3.14 75.47 ± 4.56# 53.51 ± 6.39** 46.89 ± 4.39** 57.85 ± 3.01*
Lipid peroxidation (TBARS level in μg g−1 of tissue) 4.56 ± 0.32 7.20 ± 0.45# 5.56 ± 0.57* 5.47 ± 0.33* 5.71 ± 0.49*
Protein cabonylation (nmol mg−1 of protein) 8.71 ± 0.72 17.71 ± 1.51# 13.20 ± 1.32* 11.17 ± 1.06** 11.36 ± 1.27**
Total coenzyme Q9 (nmol g−1 of wet tissue) 148.80 ± 4.31 116.50 ± 5.46# 127.33 ± 4.45 137.71 ± 5.57* 143.20 ± 4.61**
Total coenzyme Q10 (nmol g−1 of wet tissue) 25.38 ± 1.66 16.88 ± 1.78# 21.75 ± 1.87 23.60 ± 1.82* 21.32 ± 1.73
GSH (mg g−1 tissue) 25.56 ± 1.52 15.12 ± 0.98# 20.08 ± 1.43 22.32 ± 1.87** 23.60 ± 1.61**
Heart
ROS production (nmol DCF min−1 mg−1 of protein) 25.89 ± 1.46 58.14 ± 3.84# 40.77 ± 3.72** 37.83 ± 3.01** 45.94 ± 2.82**
Lipid peroxidation (TBARS level in μg g−1 of tissue) 3.55 ± 0.24 6.30 ± 0.37# 5.09 ± 0.33* 4.61 ± 0.34** 4.94 ± 0.20*
Protein cabonylation (nmol mg−1 of protein) 2.48 ± 0.26 5.09 ± 0.42# 3.73 ± 0.27* 3.06 ± 0.22** 3.02 ± 0.31**
Total coenzyme Q9 (nmol g−1 of wet tissue) 59.12 ± 2.88 43.01 ± 3.15$ 51.03 ± 3.94 54.44 ± 3.80 55.46 ± 4.30*
Total coenzyme Q10 (nmol g−1 of wet tissue) 26.87 ± 2.45 15.84 ± 1.93$ 22.42 ± 3.18 25.80 ± 2.77* 25.05 ± 2.42
GSH (mg g−1 tissue) 22.13 ± 1.54 12.28 ± 1.78# 17.40 ± 2.39 19.60 ± 1.24* 19.31 ± 1.92*
Data were expressed as mean ± SE (n = 6). $p < 0.05 compared with normal control group. #p < 0.01 compared with normal control group. *p < 0.05 compared with
diabetic control group. **p < 0.01 compared with diabetic control group. Gr I: Normal; Gr I: Normal; Gr II: T2D control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA
(200 mg/kg, p.o.); Gr V: T2D + glibenclamide (1 mg/kg, p.o.).
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in diabetic control animals. Extract treatment in either
of doses, though statistically insignificant, but definitely
improved body weight of T2D rats. In T2DM, loss of
insulin responsiveness prevented utilization of glucose
for energy to the cells. Under this situation, body starts
burning fat and muscle for energy, which would be ac-
countable for loss of body weight in diabetic control
rats. In this study, a significant increase (p < 0.01) inTable 5 Effect of AA on antioxidant enzymes viz. CAT, SOD, G
Parameters Gr I Gr II
Kidney
CAT (U mg−1 of protein) 226.34 ± 16.33 153.74 ± 9.
SOD (U mg−1 of protein) 140.32 ± 7.05 98.51 ± 6.1
GST (μmol h−1 mg−1 of protein) 0.71 ± 0.07 0.46 ± 0.04
GPx (nmol min−1 mg−1 of protein) 68.20 ± 5.91 40.43 ± 5.5
GR (nmol min−1 mg−1 of protein) 69.81 ± 4.90 41.82 ± 3.3
G6PD (nmol min−1 mg−1 of protein) 133.64 ± 7.07 97.44 ± 5.1
Heart
CAT (U mg−1 of protein) 287.50 ± 11.61 192.26 ± 10
SOD (U mg−1 of protein) 133.66 ± 7.54 95.14 ± 4.6
GST (μmol h−1 mg−1 of protein) 1.63 ± 0.13 1.07 ± 0.12
GPx (nmol min−1 mg−1 of protein) 81.49 ± 8.08 96.74 ± 7.0
GR (nmol min−1 mg−1 of protein) 26.87 ± 2.45 50.20 ± 4.2
G6PD (nmol min−1 mg−1 of protein) 101.70 ± 7.04 71.23 ± 4.2
Data were expressed as mean ± SE (n = 6). $p < 0.05 compared with normal control
diabetic control group. **p < 0.01 compared with diabetic control group. Gr I: Nor
(200 mg/kg, p.o.); Gr V: T2D + glibenclamide (1 mg/kg, p.o.).kidney weight was observed in diabetic control group
as compared with normal control rats. The enhance-
ment of kidney weight would be accountable to glom-
erular hypercellularity, increase in mesangium and
subsequent closer of glomerulus. Treatment with AA
(200 mg/kg) could significantly (p < 0.05) reverse this
effect near to the normal status. However, no signifi-
cant changes were observed in weight of heart in any of
experimental animal.ST, GPx, G6PD and GR of T2D rats
Gr III Gr IV Gr V
11# 207.28 ± 12.03* 212.65 ± 13.77* 216.33 ± 17.88*
6# 123.82 ± 6.07* 129.15 ± 6.92** 128.56 ± 6.94*
$ 0.59 ± 0.05 0.68 ± 0.06* 0.67 ± 0.04*
7$ 54.20 ± 6.12 59.93 ± 8.63 61.82 ± 6.64
1# 59.48 ± 5.63 61.63 ± 5.74* 63.85 ± 6.30*
9# 117.65 ± 7.69 125.38 ± 8.57* 126.41 ± 6.45*
.52# 230.63 ± 16.50 255.41 ± 15.18* 254.98 ± 20.62*
6# 115.45 ± 7.67 121.96 ± 7.18* 123.60 ± 7.82*
# 1.47 ± 0.10 1.53 ± 0.13* 1.55 ± 0.11*
1# 133.45 ± 10.13* 138.62 ± 10.69* 139.69 ± 8.35**
9# 67.20 ± 4.70 73.28 ± 6.67* 75.08 ± 4.69*
2# 88.48 ± 6.29 94.55 ± 4.03* 92.90 ± 4.43*
group. #p < 0.01 compared with normal control group. *p < 0.05 compared with
mal; Gr II: T2D control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA
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Imbalance in cellular redox status due to oxidative stress
participate a crucial role in diabetic pathophysiology [5].
The experimental observation confirmed that renal and
cardiac dysfunctions resulting from diabetes were ac-
companied with an alteration in the redox status within
the tissues (Tables 4 and 5). The rate of ROS production
in diabetic control group was found to be significantly
(p < 0.01) higher than that of the normal animals. The
inexorable generation of ROS during T2DM could be
correlated with the significantly (p < 0.01) elevated levels
of lipid peroxidation (TBARS) and protein carbonylation
in T2D rats. Lipid peroxidation and protein carbonyl
content are the indication of cell membrane damage and
oxidative modification of proteins. Treatment with AA
(100 and 200 mg kg−1), however, could significantly (p <
0.01) inhibit the rate of ROS production in the selected
tissues as compared to diabetic rats. Thereby, AA (100
and 200 mg kg−1) could simultaneously alleviate (p < 0.05-
0.01) that lipid peroxidation and protein carbonylation in
renal and myocardial tissues. Ubiquinones (co-enzymes
Q) function as important cellular electron carriers distrib-
uted within cell organelles chiefly in mitochondria [32].Figure 2 Effect of AA on DNA fragmentation (A), NAD (B) and ATP (C
Data were expressed as mean ± SE (n = 6). #p < 0.01 compared with normal c
compared with diabetic control group. SE in DNA fragmentation analysis repr
were changed accordingly with respect to 100% in Gr I. Gr I: Normal; Gr II: T2D
p.o.); Gr V: T2D + glibenclamide (1 mg/kg, p.o.).Co-enzymes Q9 and Q10 act as antioxidants through scav-
enging ROS and thereby inhibit lipid peroxidation. A sig-
nificant reduction of co-enzymes Q (Q9 and Q10) levels
in renal (p < 0.01) and cardiac (p < 0.05) tissues was
observed in T2D control rats as compared with normal
control animals. AA (200 mg kg−1) treatment could sig-
nificantly (p < 0.05) improve Q9 level in kidneys and Q10
levels in kidneys and hearts in T2D animals. Thiol-based
antioxidant system (GSH) contributes in cellular defense
against free radicals mediated oxidative damage. It pro-
tects cells from ROS and consequently converted into its
oxidized form, GSSG [29]. According to the present data,
the level of GSH decreased significantly (p < 0.01) due to
T2DM in rats as compared with normal animals. Oral ad-
ministration of AA (200 mg/kg) could ameliorate this al-
teration in renal (p < 0.01) and cardiac (p < 0.05) tissues as
compared with diabetic control animals, which would be
perhaps due to strong anti-radical activity of AA. Antioxi-
dant enzymes viz. CAT, SOD, GPx, GST, G6PD and GR
are first line of cellular defense against oxidative stress
[33]. In present study, T2DM caused significant depletion
in antioxidant enzymes in cardiac and renal tissues
(Table 5). Excessive generation of ROS is accountable for) levels in the renal and cardiac tissues of type 2 diabetic rats.
ontrol group. *p < 0.05 compared with diabetic control group. **p < 0.01
esent the SE of % fragmentation within individual group, while, mean
control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg,
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While, AA treatment could significantly restore the activ-
ities of antioxidant enzymes. The augmented oxidative
stress in T2DM was successfully turned-back by AA sup-
plementation indicating its prophylactic potential against
oxidative stress and associated dysfunctions in kidneys
and heart of T2D rats. The extract may perform its func-
tion by electron-transfer, radical recombination, radical
addition and/or by quenching free radicals.Effect on DNA fragmentation, NAD and ATP levels
Intercellular redox imbalance plays a key role in DNA
damage. The most reactive -OH radical reacts with DNA
bases and subtract a hydrogen atom from methyl group of
thymine base. As a result, DNA strands are ruptured, or
DNA bases are modified abnormally or DNAs are cross-
linked. The DNA fragmentation and PARP activation play
a pivotal role in cell-death process in diabetic pathophysi-
ology [34]. The DNA fragmentation percentage in renal
and myocardial tissues of experimental rats was depictedFigure 3 Western blot analysis of NF-κB (A, B, C, D) and PKC isoforms
and of type 2 diabetic rats and AA treated animals. The relative intens
arbitrary value of 1. β-actin was used as a loading protein. Data were expre
group. *p < 0.05 compared with diabetic control group. **p < 0.01 compa
T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg, p.o.); Gr V: T2D +in Figure 2A. T2DM increased DNA fragmentation in
renal and myocardial tissues significantly (p < 0.01)
amounting ~ 145 and 156%, respectively. Oral adminis-
tration of AA (200 mg/kg) inhibited DNA fragmenta-
tion in T2D rats, significantly (p < 0.05). In this study,
intracellular ATP and NAD levels in the selected tissues
were investigated (Figure 2B and C, respectively). It was
observed that, hyperglycemia caused significant (p <
0.01) reduction in intracellular NAD and ATP levels in
renal and cardiac tissues of diabetic control rats. Acti-
vation of inflammatory cytokines induces necrosis via
PARP activation during T2DM, which would be ac-
countable for the reduction of intracellular ATP levels.
Reduction of ATP level suggested that necrosis simul-
taneously participate in diabetic pathophysiology. AA
treatment, however, could significantly reinstate in cel-
lular ATP (p < 0.05) and NAD (p < 0.05-0.01) levels in
both the tissues. Therefore, it would be suggested that
AA supplementation could protect renal and myocar-
dial tissues from adverse effects of T2DM by preventing
DNA damage and PARP activation.(E, F, G, H) in the renal (A, B, E, F) and cardiac (C, D, G, H) tissues
ities of bands were determined and the control band was given an
ssed as mean ± SE (n = 6). #p < 0.01 compared with normal control
red with diabetic control group. Gr I: Normal; Gr II: T2D control, Gr III:
glibenclamide (1 mg/kg, p.o.).
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NF-κB, a ubiquitous transcription factor, gets activated
in response to oxidative stress. NF-κB plays integral
role in regulation of various inflammatory and immune
responses [35]. Therefore the expressions of NF-κB
have been investigated in the kidneys (Figure 3A,B) and
hearts (Figure 3C,D) tissues of experimental animals
under different groups. Interestingly, the expressions of
NF-κB were significantly (p < 0.01) increased in renal
and myocardial tissues of T2D rats. However, treatment
with AA (100 and 200 mg/kg) could significantly (p <
0.05-0.01) reinstate the expressions of NF-κB in the se-
lected tissues near to normalcy. Activation of PKCs within
cells during T2DM results in various pathophysiological
changes [4]. PKCs are activated via polyol pathway during
hyperglycemia [4]. Activated PKC isoforms attribute many
abnormal vascular and cellular processes and deregula-
tions viz. endothelial dysfunction, vascular permeabil-
ity, angiogenesis, apoptosis, changes in vessel dilation,Figure 4 Western blot analysis of caspase 3 (A, B, C, D), caspase 9 (E
cardiac (C, D, G, H, K, L) tissues of type 2 diabetic rats and AA treated
control band was given an arbitrary value of 1. β-actin was used as a loading
with normal control group. *p < 0.05 compared with diabetic control group.
control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg, p.o.); Gbasement membrane thickening, and extracellular matrix
expansion, alterations of enzymatic activities and alter-
ations in several transcription proteins [36,37]. Also, PKCs
could activate the expression of NF-κB under oxidative
stress [38]. Earlier reports revealed that PKC isoforms
(PKC-α, β, δ, and ε) are activated in hyperglycemia-
mediated nephropathy and cardiomyopathy [37,39].
Different isoforms of PKCs were evaluated through im-
munoblotting (Figure 3E-H). Immunoblot assays indi-
cated that, T2D rats exhibited significantly (p < 0.01)
up-regulated expressions of PKC-α, PKC-β, PKC-δ and
PKC-ε in renal (Figure 3E,F) and myocardial (Figure 3G,
H) tissues. However, the treatment with AA could signifi-
cantly (p < 0.05-0.01) reduce the expression of PKC iso-
forms in diabetic rats.
Finally, T2D-mediated intrinsic apoptotic cell death
pathway in renal and cardiac tissues was studied (Figure 4).
Oxidative stress seems to play a crtitical role in mitochon-
drial dysfunction which is an important early event in the, F, G, H), Bcl-2/Bax (I, J, K, L) in the renal (A, B, E, F, I, J) and
animals. The relative intensities of bands were determined and the
protein. Data were expressed as mean ± SE (n = 6). #p < 0.01 compared
**p < 0.01 compared with diabetic control group. Gr I: Normal; Gr II: T2D
r V: T2D + glibenclamide (1 mg/kg, p.o.).
Figure 5 Effect of AA on pro-inflammatory cytokines IL-1β (A), IL-6 (B) and TNF-α (C) levels in the renal and cardiac tissues of type 2
diabetic rats. Data were expressed as mean ± SE (n = 6). #p < 0.01 compared with normal control group. *p < 0.05 compared with diabetic
control group. **p < 0.01 compared with diabetic control group. Gr I: Normal; Gr II: T2D control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA
(200 mg/kg, p.o.); Gr V: T2D + glibenclamide (1 mg/kg, p.o.).
Figure 6 Histological sections (X 20) of kidneys (Panel A) and heart (Panel B) of normal rats (Gr I), type 2 diabetic rats (Gr II), type 2
diabetic rat treated with AA (100 mg/kg) (Gr III), type 2 diabetic rat treated with AA (200 mg/kg) (Gr IV), type 2 diabetic rat treated
with glibenclamide (1 mg/kg) (Gr V). Blue arrows represent normal glomerular structure. The green arrows showed glomerular hypercellularity.
The black arrows indicated tubular necrosis. The red arrows indicated normal radiating pattern of cardiac muscle. The black dotted arrows showed
extensive degeneration in cardiac muscle. Gr I: Normal; Gr II: T2D control, Gr III: T2D + AA (100 mg/kg, p.o.); Gr IV: T2D + AA (200 mg/kg, p.o.);
Gr V: T2D + glibenclamide (1 mg/kg, p.o.).
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apoptotic pathways are some pro- and anti-apoptotic pro-
teins and cysteinyl aspartic acid-specific proteases (cas-
pases) [7,40]. Proteins of the Bcl-2 (anti-apoptotic) family
act on the mitochondria to regulate the release of cyto-
chrome c and initiate the caspases dependent apoptotic
pathway [7]. Bax is a pro-apoptotic protein and can modu-
late the pro-apoptotic processes by inhibiting the expres-
sion of Bcl-2 members. Immunoblot analyses of caspase 3
(Figure 4A-D) and caspase 9 (Figure 4E-H) exhibited sig-
nificant (p < 0.01) up-regulation of caspases in renal and
cardiac tissues of T2D rats, which indicated apoptotic cell
damage in selected tissues with the progression of DM.
Treatment with AA, however, could significantly (p < 0.05)
arrest the over-expression of caspases in renal and myocar-
dial tissues of T2D rats. In this study, T2DM inhibited
Bcl-2 significantly and activated the Bax expressions.
Therefore, the Bcl-2 to Bax ratio was significantly (p < 0.01)
reduced in the kidney (Figure 4I,J) and hearts (Figure 4K,L)
of diabetic control rats. Supplementation of AA restored
the Bcl-2/Bax ratio thereby preventing the Bax transloca-
tion to mitochondrial membranes. The experimental
outcome could suggest that the AA treatment could at-
tenuate mitochondria dependent cell death pathway.
Effect on inflammatory mediators
There are mounting evidences that, pro-inflammatory
cytokine viz. IL-6, IL-1β and TNF-α play a key role in theFigure 7 Schematic diagram of the T2DM mediated renal and cardiac
the therapeutic sites of AA.development of diabetic cardiomyopathy and nephropathy
[4]. An increase in NF-κB expression leads to a conse-
quent increase in the concentrations of aforementioned
inflammatory cytokines in diabetic rats which are in-line
with previous studies [4,35]. Pro-inflammatory cytokines
are chief mediators of inflammatory reaction and stimu-
late the generation of acute phase proteins. These cyto-
kines function inter-dependently. For example, IL-6 works
in connection with IL-1β for synthesis of C-reactive pro-
teins [41]. The TNF-α stimulates hyperlipidemia and hep-
atic lipogenesis simultaneously reducing the sensitivity to
insulin in muscle tissues [42] and finally the necrosis of
target organs. In this study, a significant (p < 0.01) increase
in the concentrations of pro-inflammatory cytokines was
observed in T2DM rats (Figure 5A-C). However, supple-
mentation of AA could significantly reduce the levels of
IL-6, IL-1β and TNF-α in the renal and cardiac tissues of
diabetic rats in a dose-dependent manner. AA would per-
haps act through inhibition of NF-κB expression.
Effect on histology of organs
Histological study of the kidney tissues indicated that
normal cyto-architecture of glomerulus was maintained
in control rats (Figure 6, Panel A, Gr I), while, cellular
necrosis and glomerular hypercellularity was observed in
T2D rats (Figure 6, Panel A, Gr II). Rats receiving AA
(100 and 200 mg/kg) restored nearly normal glomerular
structures and renal tubules (Figure 6, Panel A, Gr IIIdysfunction and prophylactic role of AA. Dotted lines represent
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cardiac muscles and interstitial fibrosis (Figure 6, Panel
B, Gr II) as compared with normal rats (Figure 6, Panel
B, Gr I). Supplementation with AA can prevent the
disorganization of cell plates and can restore the cardiac
cyto-architecture (Figure 6, Panel B, Gr III and IV, re-
spectively) nearly similar to that of normal rats. Gliben-
clamide, a standard drug (oral hypoglycemic), was used
as a reference standard and the effect of AA was com-
pared with glibenclamide (1 mg/kg). The effect of AA at
the dose of 200 mg/kg was remained more or less
equivalent to that of comparable to that of glibenclamide
(1 mg/kg) treated type 2 diabetic animals.
Phytochemical analysis revealed presence of taraxerol
which is reported to act as stimulator of glycogen syn-
thesis in 3 T3-L1 adipocytes and as glucose-transport ac-
tivator [43]. Taraxerol is also reported to reverse insulin
resistance [44] and possesses anti-inflammatory proper-
ties [45]. Beside taraxerol, AA also contains significant
quantity of flavonoids and phenolic constituents which
are known phyto-antioxidants [7]. Therefore, a multi-
modal effect could be achieved due to presence of afore-
mentioned bio-active phytochemicals.
Earlier literatures claimed the prophylactic role of A.
augusta in diabetes [46]. Islam et al. [10] reported that
the aqueous extract of A. augusta leaves would be bene-
ficial in managing T2DM. Halim [46] reported the
prophylactic role of of aqueous extracts A. augusta roots
and A. indica leaves in combination (1:1). However, both
these studies employed alloxan-rats for antidiabetic
assay. Despite Islam et al. [10] claimed the effectiveness
of A. augusta leaves against T2DM but the experimental
protocol strongly recommends the development of
T1DM in rats which were subjected for their assay.
Along with, neither of these published literatures could
substantiate any mechanism of A. augusta leaves in dia-
betic pathophysiology nor to establish a correlation be-
tween phytochemicals and the observed activity. On
other hand, in our study an acceptable model [15] of
T2DM has been used to screen antidiabetic effect of
A. augusta leaves. Supportive data have been presented
to show the effect of streptozotocin (singly) and
streptozotocin-nicotinamide (combination) on experi-
mental rats to support the experimental model. Signifi-
cant attempts have made to show the mechanism of
action of the test material in diabetic pathophysiology.
Finally, the activity has been correlated with phyto-
chemicals present within the A. augusta leaves.
In conclusion, this study first demonstrated that AA
effectively inhibited hyperglycemia and hyperlipidemia in
T2DM, which may be due to presence of sufficient
amounts of taraxerol. Supplementation of AA decreased
oxidative stress and related inflammatory responses of
the heart and kidneys to provide reno-protection andcardio-protection in type 2 diabetic rats. The anti-
oxidant effect could be correlated to presence of phen-
olic compounds and flavonoids, while anti-inflammatory
effect could be due to taraxerol. Moreover, AA can re-
duce the PKCs activation, NF-κB and mitochondria-
dependent apoptotic signaling cascades. The overall
beneficiary, multimodal effect of AA has been depicted
in Figure 7. With these benefits and absence of any ad-
verse effects, AA may be used to treat T2DM and its as-
sociated nephropathy and cardio-myopathy. The results
provide a justification for future clinical trials of A. au-
gusta extract (chemically defined) for the development
of oral hypoglycemic agent employing natural resources.
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